Jeyser T. Gamutia BN4B WEST TOWER 4th Floor- ENT Ward Patient’s Name: H.F Age: 41 years old.

Dx: Malocclusion with multiple injuries 2° to VA January 29, 2019

DRUG MECHANISM OF
DOSAGE INDICATION CONTRAINDICATIONS ADVERSE EFFECTS NURSING RESPONSIBILITIES
ACTION

CNS: Before:
Generic Name: Dosage: Exhibits Management for  Hypersensitivity to drug,
Dizziness, drowsiness,  Assess patient’s history
Celecoxib 500mg/tab anti-inflammatory, acute pain sulfonamides, or other headache, insomnia, fatigue of allergic reaction to the drug.
 Monitor complet eblood count,
analgesic,and antipyretic NSAIDs
CV: electrolyte levels, creatinine
Brand Name: Frequency: action due to inhibition of  Severe hepatic Peripheral edema clearance, and occult fecal
blood test and liver function test
Celebrex Q8hrs the enzyme COX-2. impairment
EENT: results every 6 to 12months
 History of asthma or ophthalmic
effects,tinnitus,pharyngitis, During
Classification: Route: urticaria
rhinitis,sinusitis  Instruct patient totake drug
Analgesic Oral withfood or milk.
GI:  Teach patient to avoid aspirin
Nausea, diarrhea, and other NSAIDs (such as
constipation, abdominal ibuprofen and naproxen) during
pain,dyspepsia, therapy.
flatulence,dry mouth, GI
bleeding After:
 Advise patient to immediately
GU: report bloody stools, blood in
menorrhagia vomit, or signs or symptoms of
liver damage (nausea,
Hematologic: fatigue,lethargy, pruritus,
Decreased hemoglobin or yellowing of eyes or
hematocrit, eosinophilia skin,tenderness on upper right
side of abdomen, or flu like
symptoms)